Recombinant Human Parathyroid Hormone Related Protein 1-34 and 1-84 and Their Roles in Osteoporosis Treatment
Osteoporosis is a common disorder characterized by compromised bone strength that predisposes patients to increased fracture risk. Parathyroid hormone related protein (PTHrP) is one of the candidates for clinical osteoporosis treatment. In this study, GST Gene Fusion System was used to express recom...
Main Authors: | Wang, Hua, Liu, Jingning, Yin, Ying, Wu, Jun, Wang, Zilu, Miao, Dengshun, Sun, Wen |
---|---|
Format: | Online |
Language: | English |
Published: |
Public Library of Science
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3916416/ |
Similar Items
-
In vitro and preclinical assessment of an intranasal spray
formulation of parathyroid hormone PTH 1-34 for the treatment of osteoporosis
by: Williams, Allan J., et al.
Published: (2017) -
Parathyroid Hormone Administration Improves Bone Marrow Microenvironment and Partially Rescues Haematopoietic Defects in Bmi1-Null Mice
by: Lu, Ruinan, et al.
Published: (2014) -
Parathyroid hormone and parathyroid hormone type-1 receptor accelerate myocyte differentiation
by: Kimura, Shigemi, et al.
Published: (2014) -
A Novel Approach for High Level Expression of Soluble Recombinant Human Parathyroid Hormone (rhPTH 1-34) in Escherichia coli
by: Hamedifar, Haleh, et al.
Published: (2013) -
Effects of Intermittent Administration of Parathyroid Hormone (1-34) on Bone Differentiation in Stromal Precursor Antigen-1 Positive Human Periodontal Ligament Stem Cells
by: Wang, Xiaoxiao, et al.
Published: (2016)